Evaluating vaccines for HIV prevention using nonhuman primates
Official title: Simian Vaccine Evaluation Unit: Core Activities - Administrative and Technical Support
Funded at University of Louisiana at Lafayette · NIH-10610273 · Data updated 2026-11-12
This study is working on creating better HIV vaccines and prevention methods using monkeys to help find out how well these vaccines can protect against the virus, so we can eventually help people living with HIV.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Louisiana at Lafayette NIH-funded |
| Lab location | 1 site (Lafayette, United States) |
| Project start | April 1, 2020 |
| Project end | March 31, 2027 |
| Funding year | 2022 |
| Award (this year) | $279,978 |
| NIH project number | 75N93020D00008-P00002-759302000001-1 |
| Project ID | NIH-10610273 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research include individuals at high risk for HIV infection who may eventually receive effective vaccines developed through these studies.
✕Less likely to help
Patients who are already living with HIV or those who do not have access to vaccination programs may not receive direct benefits from this research.
What this research studies
This research focuses on the development and evaluation of effective HIV vaccines and prevention strategies through the use of nonhuman primates (NHPs). The Simian Vaccine Evaluation Units (SVEUs) provide essential resources for preclinical studies, allowing researchers to assess the immune responses generated by candidate AIDS vaccines. By conducting thorough evaluations of vaccine efficacy and identifying correlates of reduced virus acquisition, this program aims to enhance the effectiveness of clinical vaccines. The SVEUs support all stages of AIDS vaccine research, from initial evaluations to clinical testing.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective vaccines that prevent HIV infection, significantly improving public health outcomes.
How similar studies have gone: Previous research has shown success in using nonhuman primates for vaccine evaluation, indicating that this approach is both established and promising.
Where this research is happening
-
University of Louisiana at Lafayette
Lafayette, United States Active
Researchers
- Principal investigator: Villinger, Francois — University of Louisiana at Lafayette
- Study coordinator: Villinger, Francois
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.